Quarterly report pursuant to Section 13 or 15(d)

Investment in Non-Controllable Entity (Details)

v2.4.0.8
Investment in Non-Controllable Entity (Details) (Diagnostics Company [Member], USD $)
1 Months Ended 9 Months Ended
Aug. 31, 2013
Sep. 30, 2013
Diagnostics Company [Member]
   
Schedule of Cost-method Investments [Line Items]    
Cost Method Investments   $ 1,500,000
Option To Purchase   100.00%
Cost method investments, additional investment 500,000  
Collaborative arrangement, potential maximum stock option price 6,000,000  
Business Combination, Indemnification Assets, Range of Outcomes, Value, Low 1,000,000  
Business Combination, Indemnification Assets, Range of Outcomes, Value, High 2,000,000  
Royalty Percentage - Minimum range 7.00%  
Revenue Range, Minimum 50,000,000  
Royalty Percentage - Maximum Range 11.00%  
Revenue Range - Maximum   $ 100,000,000